11-71435815-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM1PM2BP4
The NM_001360.3(DHCR7):c.988G>A(p.Val330Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000411 in 1,603,764 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. V330V) has been classified as Likely benign.
Frequency
Consequence
NM_001360.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DHCR7 | NM_001360.3 | c.988G>A | p.Val330Met | missense_variant | 9/9 | ENST00000355527.8 | |
DHCR7 | NM_001163817.2 | c.988G>A | p.Val330Met | missense_variant | 9/9 | ||
DHCR7 | XM_011544777.3 | c.1122G>A | p.Pro374= | synonymous_variant | 9/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DHCR7 | ENST00000355527.8 | c.988G>A | p.Val330Met | missense_variant | 9/9 | 1 | NM_001360.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000427 AC: 65AN: 152204Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.000364 AC: 87AN: 239088Hom.: 0 AF XY: 0.000367 AC XY: 48AN XY: 130966
GnomAD4 exome AF: 0.000409 AC: 594AN: 1451442Hom.: 0 Cov.: 37 AF XY: 0.000420 AC XY: 303AN XY: 720604
GnomAD4 genome ? AF: 0.000427 AC: 65AN: 152322Hom.: 0 Cov.: 35 AF XY: 0.000457 AC XY: 34AN XY: 74472
ClinVar
Submissions by phenotype
Smith-Lemli-Opitz syndrome Uncertain:6
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | May 11, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 23, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Oct 25, 2022 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 330 of the DHCR7 protein (p.Val330Met). This variant is present in population databases (rs139724817, gnomAD 0.06%). This missense change has been observed in individual(s) with Smith–Lemli–Opitz syndrome (PMID: 12270273). ClinVar contains an entry for this variant (Variation ID: 420113). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DHCR7 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 29, 2024 | - - |
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jun 23, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 07, 2022 | Reported previously in an individual with psychomotor regression and multiple congenital abnormalities suggestive of Smith-Lemli-Opitz syndrome who had a second DHCR7 variant identified on the opposite allele; however, this patient's serum 7-DHC concentration was 100 fold lower than typical mean serum levels for affected individuals, and significantly lower than in the other patients reported in the study (Patrono et al., 2002); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23042628, 29300326, 24813812, 27401223, 15670717, 28250423, 12270273, 34426522) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 19, 2017 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 11, 2022 | Variant summary: DHCR7 c.988G>A (p.Val330Met) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00036 in 239088 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in DHCR7 causing Smith-Lemli-Opitz Syndrome (0.00036 vs 0.0043), allowing no conclusion about variant significance. c.988G>A has been reported in the literature in individuals affected with Smith-Lemli-Opitz Syndrome (example, Patrono_2002) and autism (example, Saskin_2017). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Six ClinVar submissions (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Hepatoblastoma Uncertain:1
Uncertain significance, no assertion criteria provided | research | Molecular Oncology - Human Genetics Lab, University of Sao Paulo | - | - - |
DHCR7-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 14, 2023 | The DHCR7 c.988G>A variant is predicted to result in the amino acid substitution p.Val330Met. This variant has been reported in a patient with suspected Smith-Lemli-Opitz syndrome (Patrono et al. 2002. PubMed ID: 12270273), in two patients in a large autism cohort (Table S2, Saskin et al. 2017. PubMed ID: 28250423), and in two patients with hepatoblastoma (Aguiar et al. 2022. PubMed ID: 35495172). In all cases pathogenicity was not clearly established. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at